Active substance
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ELOCTA 1000 IU POWDER FOR SOLUTION FOR INJECTION | 1000 IU | Powder and solvent for solution for injection · Intravenous use | 1 Vial | SAR 2959.05 | Biological · Prescription | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB | Valid |
| ELOCTA 1500 IU POWDER FOR SOLUTION FOR INJECTION | 1500 IU | Powder and solvent for solution for injection · Intravenous use | 1 Vial | SAR 4438.85 | Biological · Prescription | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB | Valid |
| ELOCTA 2000 IU POWDER FOR SOLUTION FOR INJECTION | 2000 IU | Powder and solvent for solution for injection · Intravenous use | 1 Vial | SAR 5918.70 | Biological · Prescription | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB | Valid |
| ELOCTA 250 IU POWDER FOR SOLUTION FOR INJECTION | 250 IU | Powder and solvent for solution for injection · Intravenous use | 1 Vial | SAR 739.30 | Biological · Prescription | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB | Valid |
| ELOCTA 3000 IU POWDER FOR SOLUTION FOR INJECTION | 3000 IU | Powder and solvent for solution for injection · Intravenous use | 1 Vial | SAR 8878.35 | Biological · Prescription | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB | Valid |
| ELOCTA 500 IU POWDER FOR SOLUTION FOR INJECTION | 500 IU | Powder and solvent for solution for injection · Intravenous use | 1 Vial | SAR 1479.25 | Biological · Prescription | SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB | Valid |
HEMOPHILIA A
Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Elocta can be used for all age groups.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.